C. elegans Model for Mycotoxin Joint Toxicity Assessment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current animal models for evaluating toxicity and metabolism of mycotoxins like tenuazonic acid and patulin are costly, time-consuming, and raise ethical concerns, making them unsuitable for quick and efficient toxicity studies.
Innovation Solution
A biological model using Caenorhabditis elegans is established by exposing L1-stage nematodes to a mixed system containing tenuazonic acid and penicillin, allowing for the creation of a joint toxic model that is easy to operate and cost-effective, enabling the study of mycotoxin joint contamination mechanisms.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If large animal models (mice, rats, rabbits) are used to evaluate mycotoxin toxicity, then the homology with humans is high, but the experimental requirements are strict, the processes are time-consuming and costly
Solution Approach 1:
The patent uses Caenorhabditis elegans as a simplified copy model that replicates essential toxicity evaluation functions of large animals. The nematode model copies the core biological responses to mycotoxins while eliminating the complexity and time constraints of mammalian models, achieving rapid toxicity assessment with maintained biological relevance
Solution Approach 2:
The patent employs short-lived Caenorhabditis elegans organisms as disposable test subjects that can be rapidly cultured and discarded after experimentation. This approach eliminates the ethical and practical constraints of using long-lived large animals, enabling high-throughput toxicity screening without the time and resource burdens of mammalian models
2Reliability
If large animal models (mice, rats, rabbits) are used to evaluate mycotoxin toxicity, then the homology with humans is high, but the experimental costs are high
Solution Approach 1:
The patent substitutes expensive large animal models with inexpensive Caenorhabditis elegans that can be mass-cultured at minimal cost. The nematodes require simple media and small space, reducing material and facility costs while maintaining sufficient biological relevance for toxicity evaluation
Solution Approach 2:
The patent creates a cost-effective copy model using C. elegans that replicates essential toxicity endpoints. This copied system provides sufficient human-relevant data for regulatory decision-making without the prohibitive costs of mammalian experimentation
3Reliability
If large animal models (mice, rats, rabbits) are used to evaluate mycotoxin toxicity, then the homology with humans is high, but the experimental processes are inconvenient and raise ethical issues
Solution Approach 1:
The patent implements a simplified copy model using C. elegans that retains essential toxicological relevance while eliminating the operational complexities and ethical constraints of large animal work. The small size and simple care requirements of nematodes make experiments highly convenient compared to handling mammals
Data Source
AI summary
A method for establishing a biological model on joint toxicity of Caenorhabditis elegans and an application thereof are provided. The method for establishing the biological model includes adding the L1-stage Caenorhabditis elegans to a mixed system of working solution of mycotoxins containing tenuazonic acid and penicillin, K-medium solution and E. coli OP50 to obtain L1-stage Caenorhabditis elegans. The biological model indicates that TeA and PAT have a synergistic effect on the growth, development and reproductive ability of Caenorhabditis elegans, and their toxicity mechanism is related to inducing nematodes and stimulating transcriptional factors of Daf-16 genes. The biological model and detection method are simple to operate and its test period is short.